CONMED (NYSE:CNMD – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare CONMED to similar companies based on the strength of its profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.
Institutional and Insider Ownership
40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 0.3% of CONMED shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for CONMED and its peers, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CONMED | 1 | 7 | 0 | 0 | 1.88 |
| CONMED Competitors | 4295 | 10588 | 18372 | 832 | 2.46 |
CONMED presently has a consensus price target of $44.00, indicating a potential downside of 13.09%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.26%. Given CONMED’s peers stronger consensus rating and higher possible upside, analysts clearly believe CONMED has less favorable growth aspects than its peers.
Valuation & Earnings
This table compares CONMED and its peers revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| CONMED | $1.37 billion | $47.06 million | 20.92 |
| CONMED Competitors | $1.87 billion | $137.20 million | 5.93 |
CONMED’s peers have higher revenue and earnings than CONMED. CONMED is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares CONMED and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CONMED | 5.36% | 13.93% | 6.26% |
| CONMED Competitors | -303.57% | -175.14% | -22.20% |
Risk & Volatility
CONMED has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, CONMED’s peers have a beta of 2.57, meaning that their average share price is 157% more volatile than the S&P 500.
Summary
CONMED peers beat CONMED on 9 of the 13 factors compared.
CONMED Company Profile
CONMED Corporation is a medical technology company that develops and markets devices and equipment for orthopedic and general surgery. Its products support minimally invasive procedures and include arthroscopy systems, powered surgical instruments, electrosurgical equipment, and endoscopic technologies. The company was founded in 1970 and serves hospitals, surgery centers, and other healthcare providers. Its products are sold in the United States and internationally.
Receive News & Ratings for CONMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED and related companies with MarketBeat.com's FREE daily email newsletter.
